Publications by authors named "Isabelle Plantier"

Claim this Profile
H
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.
Anaïs Schavgoulidze, Aurore Perrot, Xavier Leleu, Titouan Cazaubiel, Marie-Lorraine Chretien, Isabelle Plantier

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.
Lucile Bussot, Stéphanie Poulain, Morgane Nudel Ortmans, Frédéric Davi, Damien Roos-Weil, Isabelle Plantier

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease characteristics and monitoring of IDH1/IDH2-mutated acute myeloid leukemia.
Mélinda Dantec, Maxime Dufossé, Augustin Boudry, Elise Fournier, Laure Goursaud, Isabelle Plantier

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Patrice Chevallier, Thibaut Leguay, Marc Delord, Cyril Salek, Rathana Kim, Isabelle Plantier

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia.
Yves Chalandon, Philippe Rousselot, Sylvie Chevret, Jean-Michel Cayuela, Rathana Kim, Isabelle Plantier

Blood· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial.
Francois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot, Agnès-Paule Guerci-Bresler, Frédéric Maloisel, Isabelle Plantier

Leukemia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively.
Maël Heiblig, Nicolas Duployez, Alice Marceau, Delphine Lebon, Laure Goursaud, Isabelle Plantier

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.
Jill Corre, Lydia Montes, Elodie Martin, Aurore Perrot, Denis Caillot, Isabelle Plantier

Haematologica· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study.
Thomas Boyer, Fanny Gonzales, Adeline Barthélémy, Alice Marceau-Renaut, Pauline Peyrouze, Isabelle Plantier

Cancers (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts-de-France AML observatory.
Loïc Renaud, Olivier Nibourel, Alice Marceau-Renaut, Bérengère Gruson, Nathalie Cambier, Isabelle Plantier

Am J Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine for the treatment of relapsed and refractory AML in older patients.
Raphael Itzykson, Sylvain Thépot, Céline Berthon, Jacques Delaunay, Didier Bouscary, Isabelle Plantier

Leuk Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients.
Sylvain Thépot, Raphael Itzykson, Valerie Seegers, Christian Recher, Emmanuel Raffoux, Isabelle Plantier

Am J Hematol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.
Sarah Beaussant Cohen, Odile Fenneteau, Emmanuel Plouvier, Pierre-Simon Rohrlich, Gerard Daltroff, Isabelle Plantier

Orphanet J Rare Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Isabelle Plantier

Blood· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.
Bertrand Coiffier, Catherine Thieblemont, Eric Van Den Neste, Gérard Lepeu, Isabelle Plantier

Blood· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
Steven Richebourg, Olivier Theisen, Isabelle Plantier, Anne Parry, Valérie Soenen-Cornu

Genes Chromosomes Cancer· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis.
Joris Andrieux, Catherine Roche-Lestienne, Sandrine Geffroy, Christophe Desterke, Nathalie Grardel, Isabelle Plantier

Cancer Genet Cytogenet· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia.
Joris Andrieux, Jean-Loup Demory, Brigitte Dupriez, Sabine Quief, Isabelle Plantier

Genes Chromosomes Cancer· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia.
Joris Andrieux, Jean Loup Demory, Pierre Morel, Isabelle Plantier, Brigitte Dupriez

Cancer Genet Cytogenet· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis